Category Archives: SB 254

New trial exhibits in Doe v. Ladapo: DOH worked with Genspect leaders Stella O’Malley and Joe Burgo in July 2022; Hilary Cass met SEGM’s Patrick Hunter to discuss Florida’s anti-trans report; Jamie Reed’s attorney Vernadette Broyles chose the lineup of detransitioners speaking at the Board of Medicine

Doe v. Ladapo is the case brought by transgender plaintiffs in Florida challenging SB 254, a law prohibiting gender-affirming medical treatment for minors and severely restricting access to care for trans adults since its enactment on May 17, 2023. In … Continue reading

Posted in American College of Pediatricians, Catholic Medical Association, Conversion practices, COVID-19, Dekker v. Weida, Doe v. Ladapo, Gender Exploratory Therapy Association, Genspect, Influence groups, Law, Litigation, National Catholic Bioethics Center, Psychotherapy, Regret and detransition, SB 254, SEGM, Transphobia and prejudice | Leave a comment

What we’ve all been waiting for: Third amended complaint and motion for preliminary injunction filed against Florida SB 254 adult trans care restrictions, including the ban on nurse practitioner prescribers and the mandated in-person consent forms

Key takeaways: SB 254 created arbitrary and capricious roadblocks to nearly every trans adult in Florida seeking to continue their prescribed gender-affirming hormone therapy, with new restrictions and bans on the care we can receive from physicians, nurse practitioners, and … Continue reading

Posted in Dekker v. Weida, Doe v. Ladapo, Endocrinology, Ethics, Florida, Health care, Law, News, Politics, Psychology and psychiatry, SB 254, Surgery, Transgender medicine, Transphobia and prejudice | Tagged , , , , , , , , , , , | Leave a comment